A randomised study on the clinical progress of high-risk elective major gastrointestinal surgery patients treated with olive oil-based parenteral nutrition with or without a fish oil supplement
n-3 Fatty acids have clinical benefits. The primary aim of the present study was the assessment of infection in patients who underwent major high-risk elective gastrointestinal surgery receiving postoperatively fish oil (FO)-supplemented parenteral nutrition (PN), compared with those receiving a sta...
Saved in:
Published in | British journal of nutrition Vol. 104; no. 5; pp. 737 - 741 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cambridge, UK
Cambridge University Press
14.09.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | n-3 Fatty acids have clinical benefits. The primary aim of the present study was the assessment of infection in patients who underwent major high-risk elective gastrointestinal surgery receiving postoperatively fish oil (FO)-supplemented parenteral nutrition (PN), compared with those receiving a standard olive oil (OO) emulsion. The secondary aims were the assessment of anti-inflammatory response and evaluation of tolerance and safety of these emulsions. A prospective, randomised, double-blind study was performed in patients requiring at least 5 d of PN. An isoenergetic and isoproteic formula was administered: group A received OO alone, while group B received OO that was partially replaced with FO (16·6 %, w/w). End points were outcome measures (mortality, sepsis, infection, hospitalisation days and PN duration), inflammatory response (C-reactive protein (CRP), prealbumin and leucocytes) and safety (TAG and glucose metabolism, and liver and kidney function). Statistical analysis was done using Student's t test and Fisher's exact test (P < 0·05). Twenty-seven patients were evaluated, with thirteen patients receiving FO. In this group, a significantly lower incidence of infections was found (23·1 v. 78·6 %, P = 0·007). CRP, prealbumin and leucocytes were not significantly different between the groups. There were no differences in safety parameters. We conclude that high-risk surgical patients receiving FO-supplemented PN for 5 d present a lower incidence of infection. Emulsions were safe and well tolerated. |
---|---|
Bibliography: | http://dx.doi.org/10.1017/S0007114510001066 Conference presentation: This work was presented as a poster in the 30th Congress of ESPEN, Florence, Italy, 13–16 September 2008. It was selected as one of the 100 best communications of the Congress. Clinical trial registration number: 2008-007005-36.Abbreviations: FO, fish oil; OO, olive oil; PN, parenteral nutrition istex:1E123CBDDDFDA56C1EF7FDEDC77C698C0FC57B39 ark:/67375/6GQ-DW7CNBBH-Z ArticleID:00106 PII:S0007114510001066 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-News-1 ObjectType-Feature-3 |
ISSN: | 0007-1145 1475-2662 |
DOI: | 10.1017/S0007114510001066 |